FDA Inspection 1208904 — Pfizer Manufacturing Belgium NV

Pfizer Manufacturing Belgium NV — FEI 1000654629

The FDA completed an inspection of Pfizer Manufacturing Belgium NV on June 8, 2023 in Puurs-Sint-Amands. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 8, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Puurs-Sint-Amands (Belgium)

Citations

IDCFRDescription
369621 CFR 820.100(b)Documentation